Gang Lai - Universe Pharmaceuticals CEO Chairman
| UPC Stock | USD 1.93 0.14 7.82% |
Insider
Gang Lai is CEO Chairman of Universe Pharmaceuticals
| Age | 56 |
| Address | 265, Jingjiu Avenue, Ji'An, China, 343100 |
| Phone | 86 79 6840 3309 |
| Web | https://www.universe-pharmacy.com |
Universe Pharmaceuticals Management Efficiency
The company has Return on Asset of (0.0565) % which means that on every $100 spent on assets, it lost $0.0565. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5022) %, meaning that it generated no profit with money invested by stockholders. Universe Pharmaceuticals' management efficiency ratios could be used to measure how well Universe Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -0.13. The current year's Return On Capital Employed is expected to grow to -0.1. At present, Universe Pharmaceuticals' Intangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.01, whereas Total Assets are forecasted to decline to about 47.2 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Ruscetta | Im Cannabis Corp | 55 | |
| YatGai Au | Regencell Bioscience Holdings | 51 | |
| Damon Terrill | Alpha Teknova | 53 | |
| Ken Gelhaus | Alpha Teknova | 40 | |
| Melissa Angelini | Procaps Group SA | N/A | |
| Matthew Lowell | Alpha Teknova | 54 | |
| Advocate Harrosh | Im Cannabis Corp | N/A | |
| Shai Shemesh | Im Cannabis Corp | N/A | |
| Oren Shuster | Im Cannabis Corp | N/A | |
| Patricio Munoz | Procaps Group SA | 51 | |
| Michelle Chan | Regencell Bioscience Holdings | N/A | |
| Lisa McCann | Alpha Teknova | 42 | |
| Jean Filippi | Phibro Animal Health | N/A | |
| Damian Finio | Phibro Animal Health | 54 | |
| Howard CFA | Im Cannabis Corp | 59 | |
| Wai Chung | Regencell Bioscience Holdings | 47 | |
| Rinat Efrima | Im Cannabis Corp | 47 | |
Management Performance
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.0565 |
Universe Pharmaceuticals Management Team
Elected by the shareholders, the Universe Pharmaceuticals' board of directors comprises two types of representatives: Universe Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Universe. The board's role is to monitor Universe Pharmaceuticals' management team and ensure that shareholders' interests are well served. Universe Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Universe Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gang Lai, CEO Chairman | ||
| Baochang Liu, Chief Officer | ||
| Lin Yang, CFO Director |
Universe Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Universe Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.0565 | ||||
| Profit Margin | (0.69) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | (2.06 M) | ||||
| Shares Outstanding | 1.58 M | ||||
| Shares Owned By Insiders | 8.79 % | ||||
| Shares Owned By Institutions | 2.86 % | ||||
| Number Of Shares Shorted | 281.85 K | ||||
| Price To Earning | 3.02 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share (76.35) | Revenue Per Share 7.351 | Quarterly Revenue Growth (0.30) | Return On Assets (0.06) |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.